Striving to revolutionize screening mammography by leveraging the power of AI
When breast cancer is caught at stage 0 or 1, the 5-year survival rate is more than 99%.1
And yet, nearly 40% of cases aren’t caught until it’s too late.1
Our Mission, make late-stage breast cancers a rarity by dectecting them at their earliest stages using AI.
Our work, pioneer comprehensive AI solutions to improve the mammography screening process.
Today, our suite of products help:
Aid in early detection by improving consistency, confidence, and quality of care
Enable timely, personalized determination of risk
WRDensity is our AI-driven breast density software that assists radiologists in interpreting breast density to create uniformity of density assessments at a practice level
43% more consistent than radiologists when assessing patient exams across multiple years1
RIS/PACS Compatible
Trained on over 600K images from Mallinckrodt Institute of Radiology
WRRisk is our clinical decision support software for breast cancer risk assessment
PACS Integrated
Displays risk score & WRDensity data
Real-time feedback
We continue to advance our mission through new AI-driven products in development:
To bring every eligible person in for their annual screen
To drive a digital personalized screening plan
To detect every cancer at the time of screening
Find out how our products can help your business drive compliance, improve patient outcomes, and increase revenue.
